Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Merck chief Frazier's R&D-based drug price defense a tough sell for pharma
Merck chief Frazier's R&D-based drug price defense a tough sell for pharma
Merck chief Frazier's R&D-based drug price defense a tough sell for pharma
Submitted by
admin
on November 2, 2015 - 11:05am
Source:
BioPharma Dive
News Tags:
Merck
Kenneth Frazier
drug pricing
R&D
Headline:
Merck chief Frazier's R&D-based drug price defense a tough sell for pharma
Do Not Allow Advertisers to Use My Personal information
